Insights on Melatonin as an Active Pharmacological Molecule in Cancer Prevention: What's New?
Melatonin
antioxidant
apoptosis
breast cancer
metastasis
oxidative stress.
Journal
Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
01
2018
revised:
10
04
2018
accepted:
18
04
2018
pubmed:
2
5
2018
medline:
27
12
2019
entrez:
2
5
2018
Statut:
ppublish
Résumé
Along with playing an important role in circadian rhythm, melatonin is thought to play a significant role in preventing cells from damage, as well as in the inhibition of growth and in triggering apoptosis in malignant cells. Its relationship with circadian rhythms, energetic homeostasis, diet, and metabolism, is fundamental to achieve a better comprehension of how melatonin has been considered a chemopreventive molecule, though very few papers dealing with this issue. In this article, we tried to review the most recent evidence regarding the protective as well as the antitumoral mechanisms of melatonin, as related to diet and metabolic balance. From different studies, it was evident that an intracellular antioxidant defense mechanism is activated by upregulating an antioxidant gene battery in the presence of high-dose melatonin in malignant cells. Like other broad-spectrum antioxidant molecules, melatonin plays a vital role in killing tumor cells, preventing metastasis, and simultaneously keeping normal cells protected from oxidative stress and other types of tissue damage.
Identifiants
pubmed: 29714136
pii: CMC-EPUB-90107
doi: 10.2174/0929867325666180501094850
doi:
Substances chimiques
Melatonin
JL5DK93RCL
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
6304-6320Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.